Schedule 13D ownership disclosure

Opus Genetics, Inc.

Common Stock, $0.0001 par value per share · CUSIP: 67577R102

Event date: 2025-04-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Foundation Fighting Blindness Retinal Degeneration FundReported CIK 0002042266

    Shares: 9,492,171 · Class: 15.9%

  • Foundation Fight Blindness, Inc.

    Shares: 9,492,171 · Class: 15.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-064711
Form type
SCHEDULE 13D/A
Filer
Foundation Fighting Blindness Retinal Degeneration Fund
CIK
CIK 2042266
Filed
May 06, 2025
Reporting period
Apr 30, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub